Dignitana Announces Changes to Board of Directors

Lund, Sweden – 28 February 2018 – Dignitana AB, world leader in medical scalp cooling technology, today announces that three members of the Board of Directors are resigning and a slate of three new Directors has been proposed, subject to shareholder approval at a 16 March 2018 Extraordinary General Meeting of Shareholders.

Withdrawing from the board are Board Chairman Semmy Rülf, and Directors Johan Stormby and Erik Von Schenck. The proposed slate of Directors to be added includes: Thomas N. Kelly as Chairman, and Ingrid Atteryd Heiman and Mikael Wahlgren as Directors. William Cronin will continue as a Board Member and CEO of Dignitana AB.

“We would like to thank Semmy Rülf, Johan Stormby and Erik Von Schenck for their support and service to the company,” said William Cronin, CEO of Dignitana AB. “As Dignitana now moves into a new chapter, the broad and varied expertise of the proposed slate of Thomas Kelly, Ingrid Atteryd Heiman and Mikael Wahlgren will be a tremendous asset to our continued growth and development.”

The proposed slate for the Dignitana AB Board of Directors includes:

Thomas N. Kelly, Chairman of the Board

Born 1963

Thomas Kelly serves as Managing Director of KMK & Associates LLC, a private equity firm with a wide range of interests from agriculture to manufacturing. He is also a Director of The Leaders Bank, headquartered in Oak Brook, Illinois. With diverse leadership roles in numerous companies and civic organizations, Mr. Kelly is a trusted and experienced leader known for his ability to anticipate and navigate business challenges with accountability and transparency. He serves on the Boards of the Donald P. and Byrd M. Kelly Foundation, which primarily supports Catholic education in the Chicago area. He attended the University of Kansas in Lawrence, and is an active alumnus serving as member of the President’s Advisory Council.

Current Board Positions: Managing Member of KMK & Associates LLC, Director of Leaders Bank, Director of Grandstand Sportswear and Glassware, Managing Member of 3840 Greenway Circle LLC, Director of Harger Woods Corporate Center LLC, Managing Member of D.P. Kelly & Associates, DirectorOf Elarasys Worldwide LLC, Vice President of Emerald Air Co., Director of Entrust Services, Director of Whitnell & Co., Director of Continental Community Holdings, Director and Secretary of Donald P. and Byrd M. Kelly Foundation.


Ingrid Atteryd Heiman, Board Member

Born 1958

Ingrid Atteryd Heiman has worked with companies spanning the women’s health, food, pharmaceutical, biotech, life science, and financial services industries. Most recently, from 2014 to 2015 she served as Acting Chief Executive Officer of Ellen AB (Publ), a biotech company offering patented probiotic products treated to improve women’s health where she now serves as Chairman of the Board. Ms. Heiman’s leadership experience includes services as Chief Executive Officer for three successful companies, four board chairman positions, and three board member positions, primarily with those listed on OMX First North and Aktietorget which demand effective communication with the market and shareholders. She has a proven ability to successfully strategize business development and drive profit and growth. Through her years as a management consultant she has been involved in change management, efficiency optimization, strategy development and mergers and acquisitions. Ms. Heiman attended Lund University, where she obtained a degree in Business Administration, and Uppsala University where she obtained an MBA in International Business. 

Current Board Positions: Chairman of Ellen AB, Chairman of Ellen Asia Ltd., Director of Doxa, Director of Redwood Pharma, Director of Radix Kompetens AB, Director of Parkinson Research Foundation. 


Mikael Wahlgren

Board Member

Born 1965

Mikael Wahlgren is Owner and Senior Legal Adviser of Linton & Wahlgren AB and has worked as General Counsel for Alfa Laval and in-house counsel supporting several multinational Swedish and foreign listed companies including Skansa, ABB, Rolls-Royce and NCC. Mr. Wahlgren’s extensive legal expertise in Swedish and international commercial legal matters has earned him a reputation as one of the most respected and sought-out counselors in business today managing, organizing and supporting company leadership, Boards of Directors and other stakeholders with legal guidance, strategic thinking and risk awareness. He has completed the StryelseAkademien Chairmen training and EFL’s executive board member training and holds a law degree from the University of Lund in Lund, Sweden.

Current Board Positions: Board Chairman of Arc Aroma Pure AB, Board Chairman of Nattaro Labs, Board Chairman of Gran Man AB.

The proposed Board of Directors slate is subject to approval by an Extraordinary General Meeting of Shareholders which will be held on 16 March 2018. A separate invitation for the Extraordinary General Meeting will be published shortly in Post och Inrikes Tidningar and on Dignitana's website www.dignitana.se. Advertising about the notice will also take place in Svenska Dagbladet.

This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 04.15 CET 28 February 2018.

Investor Relations                                                       

Melissa Bourestom                                       

Dignitana                                                       

00 1 773 387 8504                                         

investorrelations@dignitana.com                 

Media Contact   

Caren Browning  

King + Company

00 1 212 561 7464

caren.browning@kingcompr.com

About Dignitana AB (publ)

Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. For more information visit www.dignitana.se  and www.dignicap.com

Tags:

About Us

About Dignitana AB (publ)Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser. Learn more at www.dignitana.se and www.dignicap.com.

Subscribe

Documents & Links

Quotes

As Dignitana now moves into a new chapter, the broad and varied expertise of the proposed slate of Thomas Kelly, Ingrid Atteryd Heiman and Mikael Wahlgren will be a tremendous asset to our continued growth and development.
William Cronin, CEO Dignitana AB